Sargento, Luis <br/><br/>
Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.  [electronic resource] 

 -  Drugs & aging  09 2016 
 - 675-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1179-1969 
<br/><br/><label>Standard No.: </label>10.1007/s40266-016-0393-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiotensin Receptor Antagonists--administration & dosage<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>Heart Failure, Systolic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Survivors<br/>Time Factors<br/>Treatment Outcome